Dr. Joyce N. Barlin, MD

Dr. Barlin practices at St. Peter's Health Partners Medical Associates in Schenectady, New York.

Dr. Barlin's NPI, 1962553479, was assigned on January 13, 2007. Dr. Barlin graduated from Albany Medical College in 2006. Dr. Barlin holds New York license 256046.

Dr. Barlin's primary practice is St. Peter's Health Partners Medical Associates, at 2546 Balltown Rd, Schenectady, NY 12309 in Schenectady County. The practice phone is (518) 525-5634.

Dr. Barlin's primary practice is St. Peter's Health Partners Medical Associates in Schenectady, New York. Dr. Barlin is also affiliated with Ellis Hospital. The medical group on file is St. Peter's Medical Associates. Dmand AI also links Dr. Barlin to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barlin practices, 7 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Barlin's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Barlin is licensed in New York.

CMS data shows 6,907 Medicare services from Dr. Barlin across 17 procedure codes in 2024, for 218 Medicare patients. Medicare paid $55,945 for them.

CMS counts 218 Medicare patients who saw Dr. Barlin in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Barlin's median patient age at 67, with 99% women.

In 2024, Dr. Barlin wrote 222 Medicare Part D claims for 89 patients. 93% of them were for generic drugs. CMS names the drug for 177 of them, across 5 drugs with 11 or more claims each, at $6,923 in total drug cost. In 2023, CMS named 157 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Barlin for performance year 2024, reported as part of a group. Dr. Barlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 31 procedures of removal of the uterus by Dr. Barlin, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Barlin, published from 2011 to 2024. 2012 was the busiest year, with 3. The most frequent topics are Endometrial Neoplasms, Ovarian Neoplasms and Carcinoma, Ovarian Epithelial. Dr. Barlin has published most often in Gynecol Oncol. Dr. Barlin's most frequent co-authors are Dennis S. Chi, MD, Martee L. Hensley, MD and Richard R. Barakat, MD.

Dmand AI links Dr. Barlin to 9 clinical trials, 3 of them phase 2/3 studies. 6 are still active or recruiting. Conditions studied include Fallopian Tube Diseases, Fallopian Tube Neoplasms and Carcinoma, Endometrioid. National Cancer Institute (NCI) sponsors the most, 4.

CMS Open Payments shows 164 general payments to Dr. Barlin from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 79% of the total. AstraZeneca Pharmaceuticals LP paid the most, $160,552.

Dr. Barlin graduated from Albany Medical College in 2006.